| Term 
 
        | A primary chronic, neurobiologic disease with genetic, psychosocial and environmental factors influencing its development and manifesteations |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Maladaptive patter of substance us e characterized by repeated adverse consequences related to the repeated use of the substance |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | State of adaptation that is manifested by a drug class specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of drug, administration of antagonist |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | state of adaptation in which exposure to a drug induces changes that result in a diminuition of one or more of the drug's effects over time |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Addiction is characterized by______ |  | Definition 
 
        | Chronicity, compulsion, craving (as well as impaired control over drug use and continuing despite harm) |  | 
        |  | 
        
        | Term 
 
        | T/F slow onset BZDs are preferred as party drugs because of prolonged effects |  | Definition 
 
        | False; fast onset (such as diazepam) are preferred as they are reinforcing |  | 
        |  | 
        
        | Term 
 
        | T/F withdrawal can be fatal |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | T/F switching PT to another BZD (that is a current BZD abuser) will decrease the pattern of drug abuse and dependence |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Why should BZD withdrawal PTs be tapered? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | T/F an antidote does not exist for GHB, and only supportive care is possible |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | T/F Opiate withdrawal can be fatal |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What should alcohol withdrawal be treated with? |  | Definition 
 
        | Lorazepam (2mg q1h, taper). Prevent seizures, use higher initial dose. and taper over 7-10 d. 
 Chlordiazepoxide
 |  | 
        |  | 
        
        | Term 
 
        | For what reason might BZDs be underdosed in those undergoing alcohol withdrawal? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lorazepam 2mg 3-4x/d; taper 5-7 days (ADDITIONAL 5-7 d if long acting) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Methadone (20-80mg. taper 5-10mg/d) Buprenorphine (4-32 mg/d)
 Clonidine (2mcg/kg tid 7d, taper 3d)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bromocriptine (2.5mg tid, reduces cravings) |  | 
        |  | 
        
        | Term 
 
        | What are the 3 drugs for EtOH dependence? |  | Definition 
 
        | Disulfuram, Naltrexone, Acamprosate |  | 
        |  | 
        
        | Term 
 
        | which drug causes an averse reaction to alcohol? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | which drug inhibits aldehyde dehydrogenase, resulting in acetaldehyde to accumulate? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | _______is rarely but potentially hepatotoxic |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which drug is an opiate antagonist, and attenuates the effects of alcohol? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ______ causes dose related hepatotoxicity and nausea |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which drug reduces cravings and is a glutamate modulator at the NMDA receptor? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which 2 drugs for alcohol dependence are used together for maintaining alcohol abstinence? |  | Definition 
 
        | acamprosate and naltrexone |  | 
        |  |